Skip to main content
Menu
US
US

Resource Center

Filters
Select resource types
Select products & services
Select solutions (2)
Active Filters (2)
Clear All
193 - 204 of 205 Results
Sort by: Best Match
Best Match
Title A-Z
Title Z-A
Filter & Sort
Brochure Icon   Brochure
Get Our Brochure on Luminescence Assay Technology
Get Revvity’s brochure on advanced luminescence assay technology, featuring high sensitivity and dynamic range for gene expression, cell viability, and drug development.
Application Note Icon   Application Note
Antigen-stimulated PBMC cytokine release measured by AlphaLISA bovine cytokine kits
This application note demonstrates the performance of AlphaLISA bovine cytokine kits by measuring the cytokine release from antigenstimulated PBMCs isolated from cow blood and shows how cytokine measurements are critical for understanding cell mediated immune responses during vaccine development.
Application Note Icon   Application Note
A fast and simple chemiluminescent assay for monitoring of DNA-protein interactions
In this application note, we use HepG2 nuclear extracts to demonstrate the binding of Sp1 and HNF1 transcription factors to tagged oligonucleotides containing required cognate response elements. Read this note to see the results and access detailed data compared to EMSA.
Application Note Icon   Application Note
FcRn binding assays using AlphaLISA and HTRF technologies
In this application note you will find information about how both AlphaLISA™ and HTRF™ assays can help to measure the relative affinities of therapeutic antibodies to FcRn.
Infographic Icon   Infographic
Safety rules with Revvity biotherapeutic workflows
Improve safety and efficacy of your GMP manufacturing workflows with this infographic exploring Revvity instruments, reagents and assays.
eBook Icon   eBook
Solutions for precision medicine research
Our wide range of technologies can help you gain the knowledge you need to identify genomic vulnerabilities, screen functional responses, and evaluate how well a treatment is working.
Whitepaper Icon   Whitepaper
Shifting the treatment paradigm: the promise of gene therapy for neurodegenerative diseases
Traditional treatments for neurodegenerative diseases focus on managing symptoms, but recent advancements in gene therapy offer hope for more effective and sustainable solutions. Read now!
Product Info Icon   Product Info
LANCE and LANCE Ultra TR-FRET technology product list
LANCE™ Ultra is a highly sensitive and highly reproducible no-wash proximity assay technology that combines the benefits of time resolution (TR) with fluorescence resonance energy transfer (FRET).
Whitepaper Icon   Whitepaper
Targeted protein degradation: A novel therapeutic strategy for neurodegenerative diseases
In this white paper, get details about TPD that offers a novel strategy for neurodegenerative diseases by degrading disease-linked proteins, showing promise in preclinical studies.
Technical Note Icon   Technical Note
A simple method for preparing GPCR membrane model extracts from stable cell lines for use with the HTRF GTP Gi binding assay
This Technical Note provides a detailed method for preparing GPCR membrane model extracts from stable cell lines for use with the HTRF GTP Gi binding assay, including cell culture preparation, cell lysis, membrane extraction, and assay optimization.
Flyer Icon   Flyer
Host cell contamination detection flyer
Be safe in quantifying residual host cell DNA and proteins when developing your next biologic, cell or gene therapy.
Application Note Icon   Application Note
Monitoring residual HEK293 DNA in AAV-based therapies using the HostDetect HEK293 PCR DNA quant kit
Data behind the development of the HostDetect Hek293 kit that offers a PCR-based approach for quantifying residual host cell DNA
resource-center-page-end-card-bg-illuminator.png
resource-center-page-end-card-bg-illuminator-mobile.png

Looking for technical documents?

Find the technical documents you need, ASAP, in our easy-to-search library.